ROIV Roivant Sciences Ltd Chart, History Price & Graph

Key Takeaways

• ROIV trades in a modest up‑trend, holding above its 200‑day moving average.
• Major support sits near the lower $27 range; resistance is anchored by the $30 psychological level and the 52‑week high of $30.33.
• Volume has spiked above the 30‑day average on recent rallies, signaling buying interest.
• Momentum oscillators are in a neutral zone, suggesting room for directional bias to develop.
• Technical patterns show a consolidating channel that could break higher on a decisive close above $30.

Trend Analysis

The price of ROIV has been climbing from the lower‑mid $20s into the $28–$29 band over the past six months. The stock remains above its long‑term 200‑day moving average, a classic sign of a prevailing bullish bias. However, the recent price action reflects a sideways consolidation as the market digests upcoming clinical milestones.

Support and Resistance Levels

• Primary support: The $27.00–$27.50 zone, which aligns with recent lows and the midpoint of the 50‑day moving average corridor.
• Secondary support: The 52‑week low of $10.58, now far below current levels but a potential floor in a sharp correction.
• Resistance: The $30.00–$30.33 area, representing the 52‑week high and a key psychological barrier.
• Breakout target: A clear close above $30.33 could open a swing toward the next round‑number resistance near $33.

Momentum Indicators

Relative Strength Index (RSI) readings have hovered around the 45‑55 range, indicating a neutral stance without clear overbought or oversold conditions. The MACD line remains modestly above the signal line, but the histogram has narrowed, suggesting diminishing momentum. Traders should watch for a MACD bullish crossover as confirmation of a potential upside breakout.

Moving Averages

The 50‑day moving average tracks just below the current price, offering dynamic support during pullbacks. The 100‑day average provides a secondary cushion near $27.80. With the price comfortably above the 200‑day average, the longer‑term trend remains intact.

Volume and Market Activity

Average daily volume over the past month sits around 4.6 million shares. Recent trading sessions have seen volume spikes exceeding 7 million shares, particularly on days when the price breached the $28.50 level. Elevated volume on upward moves reinforces the strength of the current consolidation.

Chart Patterns and Supply/Demand Zones

The chart illustrates a well‑defined rectangular channel spanning $27.00 to $30.00. This pattern reflects a balance of supply near the upper edge and demand near the lower edge. A decisive close above the upper trendline could flip the pattern into a bullish rectangle breakout, while a break below the lower trendline may signal a transition to a down‑trend channel.

AI Daily Buy/Sell Signals

Tickeron’s AI Daily Buy/Sell Signals leverage artificial intelligence to scan market data, technical indicators, and price patterns, generating daily buy or sell alerts for stocks and ETFs. These signals are rooted in trend recognition, momentum analysis, and historical pattern behavior, helping traders pinpoint potential entry and exit points, confirm prevailing trends, and refine their trading decisions.

Technical Outlook and Key Levels to Watch

Looking ahead, the next critical test for ROIV is a close above the $30.33 resistance. A breakout would likely trigger short covering and attract new buying, propelling the price toward the $33–$35 zone. Conversely, a failure to hold the $27.00 support could open a short‑term correction back toward the $24–$25 range, where the 200‑day average sits.

Traders should monitor:

• Price action around the $27.50–$28.00 support cluster.
• Volume spikes accompanying moves above $30.00.
• RSI momentum crossing the 55 threshold.
• MACD histogram expansion signaling renewed bullish momentum.
• Upcoming clinical and regulatory catalysts that could add directional bias.

Disclaimer

“The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.” Disclaimers and Limitations